
Pfizer Whistleblower Confirms Bioweapon Global Extermination Plan Exposed – FULL SHOW 8/4/21
Graphene Flagship, Ovarian Cancer and Gene Delivery
The segment discusses the European Union's "Graphene Flagship" and the extensive research into graphene-based hydrogels for gene delivery. Karen Kingston cites studies showing that Moderna previously researched graphene oxide for oncology treatments, specifically to induce cell death in ovarian cancer. She notes that FOIA data from Japan shows lipid nanoparticles concentrating in the ovaries and bone marrow of subjects.

